United States · 
Who invested in Immune-Onc?
Immune-Onc's investors include Stanford-StartX Fund, Light Venture and Vivo.
United States · Series B startup
Who invested in Immune-Onc
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $33MSept 2018
- Investors
- 3
The rounds
- Sept 2018
Also claim to have backed them
This firm lists Immune-Onc as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Immune-Onc
How much has Immune-Onc raised?
Immune-Onc has raised $33M across 1 round since 2018.
When did Immune-Onc last raise?
Immune-Onc's most recent round was a Series B of $33M in Sept 2018.
What was Immune-Onc's biggest round?
Its most recent round, $33M in Sept 2018, is also its largest on record.
Who backed Immune-Onc first?
Immune-Onc's first round on record, in Sept 2018, was backed by Stanford-StartX Fund, Light Venture and Vivo.
What stage is Immune-Onc at?
Immune-Onc's latest named round is a Series B, in Sept 2018.
Where is Immune-Onc based?
Immune-Onc is based in the United States.
Companies like Immune-Onc
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.